Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. 4 Grant or award Director acquired 11,852 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change · Regulation FD disclosure
  6. 4 Open-market sale Director sold 1,173 shares at $31.52 ($36,973)
  7. 8-K Event Agreement ended
  8. 8-K Event Other events
  9. 4 Grant or award Director acquired 8,446 shares (grant or award)
  10. 4 Grant or award Director acquired 8,446 shares (grant or award)
  11. 4 Grant or award Director acquired 8,446 shares (grant or award)
  12. 4 Grant or award Director acquired 8,446 shares (grant or award)
  13. 4 Grant or award Director acquired 8,446 shares (grant or award)
  14. 4 Grant or award Director acquired 8,446 shares (grant or award)
  15. 4 Grant or award Director acquired 8,446 shares (grant or award)
  16. 8-K Event Shareholder vote results · Regulation FD disclosure
  17. 4 Open-market sale Director sold 1,996 shares at $35.53 ($70,918)
  18. 8-K Event Material agreement
  19. 8-K Event Regulation FD disclosure
  20. 10-Q Report Quarterly Report

Page 20 of 87 · 1,733 filings